10:05 AM EST, 01/08/2025 (MT Newswires) -- AngioDynamics ( ANGO ) shares jumped more than 28% in recent Wednesday trading after the company reported a narrower fiscal Q2 adjusted loss and better-than-expected net sales.

The company reported fiscal Q2 adjusted loss of $0.04 per diluted share, narrowing from a loss of $0.05 a year earlier.

Net sales for the quarter ended Nov. 30 were $72.8 million, down from $79.1 million a year earlier.

Three analysts surveyed by FactSet expected $70.9 million.

The company said it now expects fiscal 2025 adjusted loss per share of $0.34 to $0.38, compared with the prior guidance of a loss of $0.38 to $0.42. It continues to expect fiscal 2025 net sales of $282 million to $288 million. Three analysts surveyed by FactSet expect $283.9 million.

Price: 12.07, Change: +2.67, Percent Change: +28.40